New uses for biological response modifiers?
Marwick
C
C
D006526:Hepatitis C / Q000628:therapy*; D006525:Hepatitis, Viral, Human / Q000628:therapy*; D006801:Humans; D007155:Immunologic Factors; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D009965:Orphan Drug Production; D011994:Recombinant Proteins
D007155:Immunologic Factors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins